We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
-15.12%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$296M
AUM Growth
-$89.5M
(-23%)
Cap. Flow
-$26.9M
Cap. Flow
% of AUM
-9.11%
Top 10 Holdings %
Top 10 Hldgs %
34.3%
Holding
190
New
6
Increased
37
Reduced
75
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$7.14M |
| 2 |
MSCI
MSCI
|
+$5.35M |
| 3 |
Amazon
AMZN
|
+$3.17M |
| 4 |
DexCom
DXCM
|
+$1.32M |
| 5 |
Vanguard Morningstar Value ETF
VTV
|
+$669K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Stryker
SYK
|
+$10.4M |
| 2 |
Hexcel
HXL
|
+$7.27M |
| 3 |
GRMN
Garmin
GRMN
|
+$6.51M |
| 4 |
Ziff Davis
ZD
|
+$5.08M |
| 5 |
FedEx
FDX
|
+$4.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.86% |
| 2 | Technology | 19.48% |
| 3 | Consumer Discretionary | 9.62% |
| 4 | Communication Services | 9.43% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.97T
| $16.9M | 5.73% |
266,320
-5,324
| -2% | -$392K |
|
2
Microsoft
MSFT
$2.9T
| $16.1M | 5.44% |
101,941
-662
| -0.6% | -$109K |
|
3
Zoetis
ZTS
$32.7B
| $9.74M | 3.3% |
82,765
-3,815
| -4% | -$502K |
|
4
Dollar General
DG
$28.4B
| $9.47M | 3.2% |
62,711
-2,390
| -4% | -$369K |
|
5
Adobe
ADBE
$105B
| $9.39M | 3.18% |
29,492
-551
| -2% | -$188K |
|
6
Thermo Fisher Scientific
TMO
$214B
| $9.38M | 3.17% |
33,056
-1,375
| -4% | -$434K |
|
7
Edwards Lifesciences
EW
$49.4B
| $8.34M | 2.82% |
132,681
-6,210
| -4% | -$448K |
|
8
Verizon
VZ
$197B
| $8.08M | 2.73% |
150,412
-4,386
| -3% | -$251K |
|
9
Home Depot
HD
$337B
| $7.21M | 2.44% |
38,642
-1,333
| -3% | -$293K |
|
10
lululemon athletica
LULU
$13.5B
| $6.78M | 2.29% |
35,742
-1,565
| -4% | -$350K |
|
11
Alphabet (Google) Class C
GOOG
$4.11T
| $6.76M | 2.29% |
116,300
-2,700
| -2% | -$183K |
|
12
Vanguard FTSE Emerging Markets ETF
VWO
$117B
| $6.58M | 2.22% |
195,977
-3,380
| -2% | -$138K |
|
|
13
L3Harris
LHX
$55.4B
| $6.27M | 2.12% |
+34,814
| New | +$7.14M |
|
14
JPMorgan Chase
JPM
$916B
| $5.92M | 2% |
65,708
-2,752
| -4% | -$334K |
|
|
15
Amazon
AMZN
$2.44T
| $5.76M | 1.95% |
59,060
+32,780
| +125% | +$3.17M |
|
16
Estee Lauder
EL
$30.4B
| $5.58M | 1.89% |
35,030
-1,510
| -4% | -$291K |
|
17
Alibaba
BABA
$276B
| $5.51M | 1.86% |
28,310
-436
| -2% | -$91K |
|
|
18
MSCI
MSCI
$42.4B
| $5.46M | 1.85% |
+18,901
| New | +$5.35M |
|
19
Medpace
MEDP
$16.3B
| $5.39M | 1.82% |
73,515
-930
| -1% | -$80.7K |
|
20
Johnson & Johnson
JNJ
$640B
| $5.38M | 1.82% |
41,068
+100
| +0.2% | +$14.2K |
|
21
Teradyne
TER
$50B
| $4.9M | 1.66% |
90,378
-4,441
| -5% | -$282K |
|
22
Comcast
CMCSA
$87.3B
| $4.85M | 1.64% |
141,009
-4,786
| -3% | -$202K |
|
|
23
Alphabet (Google) Class A
GOOGL
$4.12T
| $4.82M | 1.63% |
83,040
+700
| +0.9% | +$47.4K |
|
24
Copart
CPRT
$28.5B
| $4.74M | 1.6% |
276,620
-9,300
| -3% | -$207K |
|
25
Pfizer
PFE
$143B
| $4.55M | 1.54% |
146,800
-935
| -0.6% | -$31.9K |
|
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q1 2020 Portfolio in Review
As of Q1 2020, Dixon Hubard Feinour & Brown held 190 positions worth $296M, down 23% from $385M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Dixon Hubard Feinour & Brown withdrew a net $26.9M in Q1 2020, closing 23 positions and reducing 75 holdings. Its most notable exit was Stryker, an estimated $10.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Dixon Hubard Feinour & Brown opened a new position in L3Harris worth $6.27M.
- Dixon Hubard Feinour & Brown's largest Q1 2020 buy was L3Harris: 34,814 shares worth $6.27M.
- Dixon Hubard Feinour & Brown added most to Amazon in Q1 2020, an estimated $3.17M increase.
- Dixon Hubard Feinour & Brown's biggest Q1 2020 reduction was Zoetis, cutting an estimated $502K.
- Dixon Hubard Feinour & Brown fully exited Stryker in Q1 2020, selling an estimated $10.4M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 34% of its $296M portfolio in Q1 2020.
- Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q1 2020.
- Dixon Hubard Feinour & Brown's portfolio value fell 23% quarter-over-quarter to $296M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q1 2020, filed 15 May 2020.